MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats

Ilaria Dettori(University of Florence), Elisabetta Coppi(University of Florence)

Neuropharmacology

November 9, 2024

10.1016/j.neuropharm.2024.110214

Cited by 4

Related Papers

Covalently Binding Adenosine A3 Receptor Agonist ICBM Irreversibly Reduces Voltage-Gated Ca2+ Currents in Dorsal Root Ganglion Neurons

|Purinergic Signalling|2023|4

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist

|Neuropharmacology|2025|0

Protection From Demyelination by the Novel Adenosine Dual <scp> A <sub>2A</sub> </scp> / <scp> A <sub>2B</sub> </scp> Receptor Antagonist <scp>P626</scp> in <scp>EAE</scp> and Cultured Oligodendrocyte Precursor Cells

|Journal of Cellular and Molecular Medicine|2025|0